Letter to the Editor Re: Influence of Food With Different Fat Concentrations on Alectinib Exposure: A Randomized Crossover Pharmacokinetic Trial

Authors:
Andrew D. Frugé College of Nursing, Auburn University, Auburn, Alabama

Search for other papers by Andrew D. Frugé in
Current site
Google Scholar
PubMed
Close
 PhD, MBA, RD
,
Kristen S. Smith Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida

Search for other papers by Kristen S. Smith in
Current site
Google Scholar
PubMed
Close
 PhD, RD
,
Sylvia L. Crowder Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida

Search for other papers by Sylvia L. Crowder in
Current site
Google Scholar
PubMed
Close
 PhD, RDN
, and
Wendy Demark-Wahnefried Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama
O’Neal Comprehensive Cancer Center, Birmingham, Alabama

Search for other papers by Wendy Demark-Wahnefried in
Current site
Google Scholar
PubMed
Close
 PhD, RD
Restricted access
  • Collapse
  • Expand
  • 1.

    Lanser DAC, de Leeuw SP, Oomen-de Hoop E, et al. Influence of food with different fat concentrations on alectinib exposure: a randomized crossover pharmacokinetic trial. J Natl Compr Canc Netw 2023;21:645651.e641.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Le Roy CI, Kurilshikov A, Leeming ER, et al. Yoghurt consumption is associated with changes in the composition of the human gut microbiome and metabolome. BMC Microbiol 2022;22:39.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Dhar R, Chakraborty M, Dutta TK. A comprehensive assessment of the antimicrobial and immunomodulatory effects of frequently consumed fermented foods: insights in the management of COVID-19. J Appl Microbiol 2023;134:lxac034.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Morcos PN, Guerini E, Parrott N, et al. Effect of food and esomeprazole on the pharmacokinetics of alectinib, a highly selective ALK inhibitor, in healthy subjects. Clin Pharmacol Drug Dev 2017;6:388397.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 884 884 23
PDF Downloads 503 503 12
EPUB Downloads 0 0 0